frnt raises €2.7M Bridge round

The company continues to build its capital base and human capital infrastructure for distribution and development of the firm's OTC Derivatives products, SEMs (Synthetic Exposure Mechanisms) and other technology and consulting services, and to prepare for its proposed initial public offering on the TSX Venture Exchange.

Source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGtke3b7tfsYKQyBo1HQa4qPnCVFJeUrIIpw8eiYQ8WELJjcVl9JgHQXZ6ACghEqg346FgigcgkmnUtfuCn_ip4UGYdEG0dusm5rMNm5nO5JuehlzcN5DJV9WKHEAlpY-YTffSmbWvTsFlzTKEg2JfIxQ3mTO0I5LMjKwPTaWEtHEO_uRke1yOTKMI-NF34izdsHIPLXwE=